ai

Post-Market Monitoring

A systematic process for collecting and reviewing experience gained from AI systems after they are placed on the market. It aims to identify unforeseen risks, ensure continued compliance with regulations like the EU AI Act (Article 72), and trigger necessary corrective and preventive actions to maintain safety and performance.

Curated by Winners Consulting Services Co., Ltd.

Questions & Answers

What is post-market monitoring?

Originating from regulated fields like medical devices (ISO/TR 20416:2020), post-market monitoring (PMM) is a cornerstone of AI governance. As mandated by the EU AI Act (Article 72), it is a proactive, systematic process for providers of high-risk AI systems to continuously collect and analyze real-world performance data after market deployment. This system must be proportionate to the AI's risk level. PMM forms a critical feedback loop within the risk management lifecycle (ISO 31000), shifting compliance from a one-time, pre-market assessment to a dynamic, ongoing process. It is distinct from 'market surveillance,' which is conducted by public authorities. The provider's PMM system is designed to identify unforeseen risks, monitor for performance degradation, and trigger necessary corrective and preventive actions (CAPA), ensuring the AI system remains safe, effective, and compliant throughout its operational life.

How is post-market monitoring applied in enterprise risk management?

Practical application of PMM involves a structured approach. First, develop a PMM Plan as part of the technical documentation (EU AI Act, Annex IV), outlining data sources (e.g., user feedback, performance metrics), collection methods, and analysis procedures. Second, implement the system by deploying tools for data aggregation and analysis, such as MLOps dashboards and user reporting channels. Third, establish a process for regular data review and action. For example, a Taiwanese medical AI firm could monitor its algorithm's accuracy on new patient demographics, achieving a 99% compliance rate with its stated performance claims. If analysis reveals a significant risk or a serious incident, the provider must take immediate corrective action and notify relevant authorities (Article 73), reducing potential liabilities and improving patient safety. This process can lead to measurable benefits like a 20% reduction in adverse events.

What challenges do Taiwan enterprises face when implementing post-market monitoring?

Taiwanese enterprises face several challenges. First, navigating regulatory complexity between the EU AI Act and local laws like the Personal Data Protection Act, especially concerning cross-border data transfers. Second, resource constraints, as SMEs may lack the budget and specialized MLOps talent to build and operate a compliant PMM system. Third, data availability and quality; collecting sufficient, unbiased real-world data to detect subtle performance drift is a significant technical hurdle. To overcome these, companies should conduct a gap analysis against Article 72, prioritize a risk-based implementation, and leverage scalable cloud platforms. Engaging compliance experts can help map legal requirements, while adopting privacy-enhancing technologies can mitigate data transfer risks. A priority action is to establish a cross-functional team to own the PMM process within the first quarter of market entry.

Why choose Winners Consulting for post-market monitoring?

Winners Consulting specializes in post-market monitoring for Taiwan enterprises, delivering compliant management systems within 90 days. Free consultation: https://winners.com.tw/contact

Related Services

Need help with compliance implementation?

Request Free Assessment